Literature DB >> 20625700

Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients.

S Tanaka1, K Narusawa, H Onishi, M Miura, A Hijioka, Y Kanazawa, S Nishida, S Ikeda, T Nakamura.   

Abstract

UNLABELLED: In patients with femoral neck fracture, clinical factors, bone metabolism markers (in serum, urine, and bone), bone mineral density, radiographic parameters, and bone histomorphometric parameters were investigated to detect determinants of fragility fracture. The osteocalcin/deoxypyridinoline ratio and osteopontin/calcium ratio of cortical bone were selected as significant predictors.
INTRODUCTION: Measurement of bone mineral density is widely used to assess bone strength, but this also depends on other bone components and on bone structure. The objective of this study was to investigate risk factors for fracture related to bone quality, the patient's history, and the patient's lifestyle.
METHODS: Twenty-one patients with femoral neck fracture and 18 patients with osteoarthritis were enrolled. Blood and urine samples were collected on admission to hospital, and bone samples were obtained from femoral necks resected during surgery. Multivariate logistic regression analysis was performed using osteoarthritis and femoral neck fracture as combined variables to assess the influence of alcohol or coffee intake, eating natto (fermented soybeans), osteocalcin and calcium concentrations, the osteocalcin/deoxypyridinoline ratio and osteopontin/calcium ratios of cortical bone and cancellous bone, various bone histomorphometric parameters, the bone mineral density of the lumbar spine and the intact contralateral femoral neck, and various radiographic parameters of the spine
RESULTS: By forward stepwise multivariate analysis, the osteocalcin/deoxypyridinoline and osteopontin/calcium ratios of cortical bone were selected as significant factors for fracture (the odds ratios were 0.493 and <0.001, respectively; both P<0.001).
CONCLUSIONS: A decrease of osteopontin and osteocalcin in bone is important for promoting vulnerability to hip fracture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625700     DOI: 10.1007/s00198-010-1328-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

Review 2.  The role of collagen in bone strength.

Authors:  S Viguet-Carrin; P Garnero; P D Delmas
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

3.  Effects of non-enzymatic glycation on cancellous bone fragility.

Authors:  S Y Tang; U Zeenath; D Vashishth
Journal:  Bone       Date:  2006-12-21       Impact factor: 4.398

Review 4.  The role of the collagen matrix in skeletal fragility.

Authors:  Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2007-06       Impact factor: 5.096

5.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Spatial clustering of remodeling osteons in the femoral neck cortex: a cause of weakness in hip fracture?

Authors:  G R Jordan; N Loveridge; K L Bell; J Power; N Rushton; J Reeve
Journal:  Bone       Date:  2000-03       Impact factor: 4.398

7.  Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women.

Authors:  W Yu; C C Glüer; T Fuerst; S Grampp; J Li; Y Lu; H K Genant
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

8.  Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin.

Authors:  M Ishijima; S R Rittling; T Yamashita; K Tsuji; H Kurosawa; A Nifuji; D T Denhardt; M Noda
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

9.  Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women.

Authors:  Tomohiko Urano; Ken'ichiro Narusawa; Masataka Shiraki; Takahiko Usui; Noriko Sasaki; Takayuki Hosoi; Yasuyoshi Ouchi; Toshitaka Nakamura; Satoshi Inoue
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

10.  Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.

Authors:  M Saito; S Mori; T Mashiba; S Komatsubara; K Marumo
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 5.071

View more
  18 in total

1.  Severity of aortic calcification is positively associated with vertebral fracture in older men--a densitometry study in the STRAMBO cohort.

Authors:  P Szulc; E J Samelson; E Sornay-Rendu; R Chapurlat; D P Kiel
Journal:  Osteoporos Int       Date:  2012-08-08       Impact factor: 4.507

Review 2.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

3.  Influence of carboxylation on osteocalcin detection by mass spectrometry.

Authors:  Timothy P Cleland; Corinne J Thomas; Caren M Gundberg; Deepak Vashishth
Journal:  Rapid Commun Mass Spectrom       Date:  2016-10-15       Impact factor: 2.419

4.  Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Tatsuhiko Kuroda; Nobuaki Miyakawa; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2013-07-05       Impact factor: 2.626

5.  The potential anti-osteoporotic effect of exercise-induced increased preptin level in ovariectomized rats.

Authors:  Khaled Abdelfattah Abulfadle; Rania Refaat Abdelkader Atia; Heba Osama Mohammed; Rania Saad Ramadan; Nourelhuda A Mohammed
Journal:  Anat Sci Int       Date:  2022-05-04       Impact factor: 1.741

6.  Distribution of vitamin K2 in subchondral bone in osteoarthritic knee joints.

Authors:  Yoshinori Ishii; Hideo Noguchi; Mitsuhiro Takeda; Junko Sato; Noriaki Yamamoto; Hiroyuki Wakabayashi; Junkichi Kanda; Shin-ichi Toyabe
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-10-16       Impact factor: 4.342

Review 7.  The relationship between osteoarthritis and osteoporosis.

Authors:  Gun-Il Im; Min-Kyu Kim
Journal:  J Bone Miner Metab       Date:  2013-11-07       Impact factor: 2.626

8.  Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture.

Authors:  Alexander Fisher; Wichat Srikusalanukul; Michael Davis; Paul Smith
Journal:  Int J Endocrinol       Date:  2012-02-22       Impact factor: 3.257

9.  A Bibliometric Analysis of Fragility Fractures: Top 50.

Authors:  Nicolas Vuillemin; Hans-Christoph Pape; Pol Maria Rommens; Kurt Lippuner; Klaus-Arno Siebenrock; Marius Johann Keel; Johannes Dominik Bastian
Journal:  Medicina (Kaunas)       Date:  2021-06-21       Impact factor: 2.430

10.  Bone quality in diabetes.

Authors:  Mitsuru Saito; Keishi Marumo
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.